Jiangsu Hengrui Pharma IPO Lockup - US$850m Cornerstone Release
Jiangsu Hengrui Pharmaceuticals (1276 HK), a China-based pharmaceutical company, raised around US$1.5bn in its H-share listing in May 2025. The...
431 Views
CX Daily: China Puts Industry, Consumers at Heart of Next Five-Year Plan
In Depth: China Puts Industry, Consumers at Heart of Next Five-Year Plan Investors Flock to Chinese eVTOLs Chasing Regulatory Green Lights Hong...
153 Views
Klook Pre-IPO - The Negatives - Disclosures Lagging
Klook (KLK US), a pan-regional experiences platform in Asia-Pacific, aims to raise around US$500m in its US listing. In this note, we talk about...
372 Views
CX Daily: China Should Launch Property Tax at āAppropriate Time,ā Ex-Finance Chief Says
TOP STORY China Should Launch Property Tax at āAppropriate Time,ā Ex-Finance Chief Says A nationwide property tax, though difficult to implement...
238 Views
Klook Pre-IPO - The Positives - Growth Has Been Very Strong
Klook (KLK US), a pan-regional experiences platform in Asia-Pacific, aims to raise around US$500m in its US listing. In this note, we talk about...
244 Views